Literature DB >> 9292254

Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).

E B Dreyer1, C L Grosskreutz.   

Abstract

Glaucoma is a leading cause of blindness worldwide and the second leading cause of irreversible blindness in the United States. The most common form of glaucoma, primary open angle glaucoma, is characterized by a chronically elevated intraocular pressure in the absence of any demonstrable structural abnormalities in the eye. The pathologic hallmark of glaucomatous optic neuropathy is the selective death of retinal ganglion cells, generally attributed to an elevated intraocular pressure. However, the histopathology of glaucomatous injury is strikingly similar to the pattern seen with the administration of toxic levels of glutamate. We have found that glaucoma is associated with elevated levels of intraocular glutamate-to a level toxic to ganglion cells. We propose that an elevation of vitreal glutamate may be responsible, at least in part, for the loss of ganglion cells seen in open angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292254

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  10 in total

Review 1.  Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.

Authors:  Stuart A Lipton
Journal:  NeuroRx       Date:  2004-01

2.  Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow.

Authors:  S L Hosking; E J Roff Hilton; S J Embleton; A K Gupta
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  The effects of excitatory amino acids and their transporters on function and structure of the distal retina in albino rabbits.

Authors:  E Levinger; E Zemel; I Perlman
Journal:  Doc Ophthalmol       Date:  2012-09-30       Impact factor: 2.379

Review 4.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

Review 5.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

Review 6.  Molecular complexity of primary open angle glaucoma: current concepts.

Authors:  Kunal Ray; Suddhasil Mookherjee
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

7.  Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway.

Authors:  Katharina Bell; Corina Wilding; Sebastian Funke; Norbert Pfeiffer; Franz H Grus
Journal:  BMC Ophthalmol       Date:  2015-06-27       Impact factor: 2.209

Review 8.  Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.

Authors:  Cinzia Rapino; Daniel Tortolani; Lucia Scipioni; Mauro Maccarrone
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

Review 10.  Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.

Authors:  Despina Kokona; Panagiota-Christina Georgiou; Mihalis Kounenidakis; Foteini Kiagiadaki; Kyriaki Thermos
Journal:  Neural Plast       Date:  2016-01-06       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.